BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23208013)

  • 1. MCARD-mediated gene transfer of GRK2 inhibitor in ovine model of acute myocardial infarction.
    Swain JD; Fargnoli AS; Katz MG; Tomasulo CE; Sumaroka M; Richardville KC; Koch WJ; Rabinowitz JE; Bridges CR
    J Cardiovasc Transl Res; 2013 Apr; 6(2):253-62. PubMed ID: 23208013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AAV6-βARKct gene delivery mediated by molecular cardiac surgery with recirculating delivery (MCARD) in sheep results in robust gene expression and increased adrenergic reserve.
    Katz MG; Fargnoli AS; Swain JD; Tomasulo CE; Ciccarelli M; Huang ZM; Rabinowitz JE; Bridges CR
    J Thorac Cardiovasc Surg; 2012 Mar; 143(3):720-726.e3. PubMed ID: 22143102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of high-dose adeno-associated virus 9 encoding sarcoplasmic reticulum Ca(2+) adenosine triphosphatase delivered by molecular cardiac surgery with recirculating delivery in ovine ischemic cardiomyopathy.
    Katz MG; Fargnoli AS; Williams RD; Steuerwald NM; Isidro A; Ivanina AV; Sokolova IM; Bridges CR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1065-72, 1073e1-2; discussion1072-3. PubMed ID: 25037619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model.
    Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ
    Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac-selective expression of extracellular superoxide dismutase after systemic injection of adeno-associated virus 9 protects the heart against post-myocardial infarction left ventricular remodeling.
    Konkalmatt PR; Beyers RJ; O'Connor DM; Xu Y; Seaman ME; French BA
    Circ Cardiovasc Imaging; 2013 May; 6(3):478-86. PubMed ID: 23536266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
    Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
    Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac progenitor cells engineered with βARKct have enhanced β-adrenergic tolerance.
    Khan M; Mohsin S; Toko H; Alkatib M; Nguyen J; Truffa S; Gude N; Chuprun K; Tilley DG; Koch WJ; Sussman MA
    Mol Ther; 2014 Jan; 22(1):178-85. PubMed ID: 24002692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ventricular dysfunction after cardioplegic arrest is improved after myocardial gene transfer of a beta-adrenergic receptor kinase inhibitor.
    Tevaearai HT; Eckhart AD; Shotwell KF; Wilson K; Koch WJ
    Circulation; 2001 Oct; 104(17):2069-74. PubMed ID: 11673348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction.
    Shah AS; White DC; Emani S; Kypson AP; Lilly RE; Wilson K; Glower DD; Lefkowitz RJ; Koch WJ
    Circulation; 2001 Mar; 103(9):1311-6. PubMed ID: 11238278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failure.
    Rengo G; Lymperopoulos A; Zincarelli C; Donniacuo M; Soltys S; Rabinowitz JE; Koch WJ
    Circulation; 2009 Jan; 119(1):89-98. PubMed ID: 19103992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.
    Raake PW; Vinge LE; Gao E; Boucher M; Rengo G; Chen X; DeGeorge BR; Matkovich S; Houser SR; Most P; Eckhart AD; Dorn GW; Koch WJ
    Circ Res; 2008 Aug; 103(4):413-22. PubMed ID: 18635825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac surgical delivery of the sarcoplasmic reticulum calcium ATPase rescues myocytes in ischemic heart failure.
    Fargnoli AS; Katz MG; Yarnall C; Isidro A; Petrov M; Steuerwald N; Ghosh S; Richardville KC; Hillesheim R; Williams RD; Kohlbrenner E; Stedman HH; Hajjar RJ; Bridges CR
    Ann Thorac Surg; 2013 Aug; 96(2):586-95. PubMed ID: 23773730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling.
    Fish KM; Ladage D; Kawase Y; Karakikes I; Jeong D; Ly H; Ishikawa K; Hadri L; Tilemann L; Muller-Ehmsen J; Samulski RJ; Kranias EG; Hajjar RJ
    Circ Heart Fail; 2013 Mar; 6(2):310-7. PubMed ID: 23271792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.
    Blom AS; Pilla JJ; Gorman RC; Gorman JH; Mukherjee R; Spinale FG; Acker MA
    Heart Fail Rev; 2005 Jun; 10(2):125-39. PubMed ID: 16258720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute ischemic cardiac dysfunction is attenuated via gene transfer of a peptide inhibitor of the beta-adrenergic receptor kinase (betaARK1).
    Tevaearai HT; Walton GB; Keys JR; Koch WJ; Eckhart AD
    J Gene Med; 2005 Sep; 7(9):1172-7. PubMed ID: 15880449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spacial and Temporal Patterns of Gene Expression After Cardiac MEK1 Gene Transfer Improve Post-Infarction Remodeling Without Inducing Global Hypertrophy.
    Fan Y; Yang YL; Yeh CC; Mann MJ
    J Cell Biochem; 2017 Apr; 118(4):775-784. PubMed ID: 27639174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial gene delivery using molecular cardiac surgery with recombinant adeno-associated virus vectors in vivo.
    White JD; Thesier DM; Swain JB; Katz MG; Tomasulo C; Henderson A; Wang L; Yarnall C; Fargnoli A; Sumaroka M; Isidro A; Petrov M; Holt D; Nolen-Walston R; Koch WJ; Stedman HH; Rabinowitz J; Bridges CR
    Gene Ther; 2011 Jun; 18(6):546-52. PubMed ID: 21228882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarction.
    Schumacher SM; Gao E; Zhu W; Chen X; Chuprun JK; Feldman AM; Tesmer JJ; Koch WJ
    Sci Transl Med; 2015 Mar; 7(277):277ra31. PubMed ID: 25739765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to systolic dysfunction in the myocardium from chronically infarcted spontaneously hypertensive rats.
    Norton GR; Veliotes DG; Osadchii O; Woodiwiss AJ; Thomas DP
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H372-8. PubMed ID: 17993597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlled release of matrix metalloproteinase-1 plasmid DNA prevents left ventricular remodeling in chronic myocardial infarction of rats.
    Lin X; Jo H; Ishii TM; Fujita M; Fu M; Tambara K; Yamamoto M; Tabata Y; Komeda M; Matsuoka S
    Circ J; 2009 Dec; 73(12):2315-21. PubMed ID: 19797822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.